Nello Mainolfi, CEO: Kymera Therapeutics KYMR Sell · Filed 02/25

Trade details

Type: Insider sale
Amount: $1,774,411.92
Shares · price: 19,764 sh · $89.78 a share
Held after: 676,431 sh
Stock: Kymera Therapeutics KYMR
Person: Nello MainolfiCEO
Trade date: 26/02/25
Filed: 26/02/25
Days to filing: 0 days

Sold 2.8% of holdings

Share of holding sold: 2.8%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 01/26~03/27

Nello Mainolfi's recent trades

Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$949.7K
8,230 sh
$949.7K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$869.8K
7,601 sh
$869.8K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$619K
5,506 sh
$619K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$552.2K
4,876 sh
$552.2K
Filed 10/01
Traded 10/01
Nello MainolfiCEO
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$392.8K
3,525 sh
$392.8K
Filed 10/01
Traded 10/01

Nello Mainolfi, CEO — sold $1.8M of Kymera Therapeutics KYMR · 2.8% of holdings · 10b5-1 plan | Whalegun